About
Epicrispr Biotechnologies develops therapies that utilize epigenome modulation to precisely control gene expression for the treatment of complex diseases.
Explore Epicrispr Biotechnologies's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.